Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents

Journal of Asian Natural Products Research

Volumn 12, Issue 3, 2010, Pages 227-232

  Tatsuzaki, Jin ^a   Nakagawa Goto, Kyoko ^a   Tokuda, Harukuni ^b   Lee, Kuo Hsiung ^a  

^a University of North Carolina   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Antitumor promoting effect; Dehydrozingerone; Epstein Barr virus; Two stage carcinogenesis

Indexed keywords

CURCUMIN; DEHYDROZINGERONE; ISOEUGENOL; PHORBOL 13 ACETATE 12 MYRISTATE; PRENYLATED DEHYDROZINGERONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL GROWTH; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; EPSTEIN BARR VIRUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRENYLATION;

ANTICARCINOGENIC AGENTS; ANTIGENS, VIRAL; CARCINOGENS; COMBINATORIAL CHEMISTRY TECHNIQUES; CURCUMIN; MOLECULAR STRUCTURE; STEREOISOMERISM; STYRENES; TETRADECANOYLPHORBOL ACETATE;

HUMAN HERPESVIRUS 4;

EID: 77951456090     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286021003591617     Document Type: Article

References (20)

1. Y. Sugiyama, S. Kawakishi, and T. Osawa, Biochem. Pharmacol. 52, 519 (1996).
2. A.J. Rudy, G. Kuttan, K.D. Babu, K.N. Rajasekharan, and R. Kuttan, Cancer Lett. 94, 79 (1995).
3. M.T. Huang, R.C. Smart, C.Q. Wong, and A.H. Conney, Cancer Res. 48, 5941 (1988).
4. J. Ishida, M. Kozuka, H. Wang, T. Konoshima, H. Tokuda, M. Okuda, X.Y. Mou, H. Nishino, N. Sakurai, K.H. Lee, and M. Nagai, Cancer Lett. 159, 135 (2000).
5. J. Ishida, M. Kozuka, H. Tokuda, H. Nishino, S. Nagumo, and K.H. Lee, Bioorg. Med. Chem. 10, 3361 (2002).
6. N. Motohashi, C. Yamagami, H. Tokuda, T. Konoshima, Y. Okuda, T. Mukainaka, H. Nishino, and Y. Saito, Cancer Lett. 134, 37 (1998).
7. C. Ito, M. Itoigawa, H. Furukawa, E. Ichiishi, T. Mukainaka, M. Okuda, M. Ogata, H. Tokuda, and H. Nishino, Cancer Lett. 142, 49 (1999).
8. C. Ito, M. Itoigawa, T. Otsuka, H. Tokuda, H. Nishino, and H. Furukawa, J. Nat. Prod. 63, 1344 (2000).
9. M. Itoigawa, C. Ito, H. Tokuda, F. Enjo, H. Nishino, and H. Furukawa, Cancer Lett. 214, 165 (2004).
10. C. Ito, M. Itoigawa, T. Takakura, N. Ruangrungsi, F. Enjo, H. Tokuda, H. Nishino, and H. Furukawa, J. Nat. Prod. 66, 200 (2003).
11. C. Ito, M. Itoigawa, N. Kojima, H. Tokuda, T. Hirata, H. Nishino, and H. Furukawa, J. Nat. Prod. 67, 1125 (2004).
12. T. Akihisa, H. Tokuda, M. Ukiya, M. Iizuka, S. Schneider, K. Ogasawara, T. Mukainaka, K. Iwatsuki, T. Suzuki, and H. Nishino, Cancer Lett. 201, 133 (2003).
13. C. Ito, M. Itoigawa, Y. Miyamoto, S. Onoda, K.S. Rao, T. Mykainaka, H. Tokuda, H. Nishino, and H. Furukawa, J. Nat. Prod. 66, 206 (2003).
14. M. Itoigawa, C. Ito, T.S. Wu, F. Enjo, H. Tokuda, H. Nishino, and H. Furukawa, Cancer Lett. 193, 133 (2003).
15. J. Tatsuzaki, K.F. Bastow, K. Nakagawa- Goto, S. Nakamura, H. Itokawa, and K.H. Lee, J. Nat. Prod. 69, 1445 (2006).
16. M. Takasaki, T. Konoshima, K. Fujitani, S. Yoshida, H. Nishimura, H. Tokuda, H. Nishino, A. Iwashima, and M. Kozuka, Chem. Pharm. Bull. (Tokyo) 38, 2737 (1990).
17. H. Tokuda, H. Ohigashi, K. Koshimizu, and Y. Ito, Cancer Lett. 33, 279 (1986).
18. G. Henle and W. Henle, J. Bacteriol. 91, 1248 (1966).
19. T. Konoshima,M. Takasaki, T. Tatsumoto, M. Kozuka, R. Kasai, O. Tanaka, R. Nie, H. Tokuda, H. Nishino, and A. Iwashima, Biol. Pharm. Bull. 17, 668 (1994).
20. N. Sakurai, M. Kozuka, H. Tokuda, Y. Nobukuni, J. Takayasu, H. Nishino, A. Kusano, G. Kusano, M. Nagai, Y. Sakurai, and K.H. Lee, Bioorg. Med. Chem. 11, 1137 (2003).